Pharming Group N.V. (PHAR) Amount of Cash per Share

The primary driver for Pharming Group N.V. (PHAR) is its strong scientific staff and ethical approach to treating rare pathologies. The cash per share distribution on the GURU.Markets daily chart shows that the value has stabilized at 2.66. Market capitalization relies on the sale of patented biologics, while business resilience is guaranteed by strict regulatory barriers and manufacturing complexity, which preclude the emergence of cheap generics.
Comprehensive metric breakdowns and analytics for pharming.com (PHAR)

Stable insurance payouts for lifelong rare disease therapies create a significant liquidity reserve for Pharming Group N.V. (PHAR). The trend in liquid assets per share, calculated as the ratio of net cash resources to the number of securities, allows for a real-time assessment of capital value and the identification of fair entry points, eliminating market noise when analyzing the asset's investment attractiveness.